Generate Biomedicines, Inc. (NASDAQ:GENB)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Loses money on what it sells.
- Revenue
- $32.5M
- Net income
- -$222.8M
- Net margin
- -685.9%
Little or no net debt.
- Total debt
- $62.6M
- Cash
- $135.4M
- Debt / equity
- 0.14
Comfortably covers what is due within a year.
- Current assets
- $470.3M
- Current liabilities
- $56.6M
- Current ratio
- 8.30
Consumes cash and must keep raising it.
- Operating cash flow
- -$240.3M
- Free cash flow
- -$245.9M
- FCF margin
- -756.9%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 128.2M
- Share growth (1y)
- —
- Cash runway
- 7 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
GENB Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 6.31 M | 7.22 M | 10.13 M | 8.82 M |
| Revenue Growth (YoY) | — | — | — | — |
| Cost of Revenue | 0.00 | 3.27 M | 0.00 | 0.00 |
| Gross Profit | 6.31 M | 3.95 M | 10.13 M | 8.82 M |
| SG&A Expense | 13.60 M | 13.50 M | 10.54 M | 10.15 M |
| R&D Expense | 64.33 M | 54.56 M | 59.73 M | 46.83 M |
| Operating Expenses | 77.93 M | 68.06 M | 70.28 M | 56.97 M |
| Operating Income | -71.61 M | -64.11 M | -60.15 M | -48.15 M |
| Pretax Income | -67.20 M | -61.69 M | -56.70 M | -44.26 M |
| Tax Provision | 53.00 K | 28.00 K | 44.00 K | 56.00 K |
| Net Income | -67.25 M | -61.45 M | -52.43 M | -41.69 M |
| EPS (Basic) | -0.52 | -0.54 | -0.63 | -0.52 |
| EPS (Diluted) | -0.52 | -0.54 | -0.63 | -0.52 |
| Shares Outstanding | 128.24 M | 128.19 M | 102.31 M | 102.31 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.